Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Totilac vs Ringer's Lactate for Hemorrhagic Shock Resuscitation
NCT01433276Phase 3Completed
- Sponsor
- Innogene Kalbiotech
- Start
- Jul 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hypertonic sodium lactate in hemorrhagic shock (2 arms), sponsored by Innogene Kalbiotech. Primary endpoint: Urinary output at 3 hours. Started Jul 2009; status: completed.
02
Drugs
hypertonic sodium lactate
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT01433276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433276.